News Detail

Bengaluru, 22 Feb 2025: Bengaluru-based biotechnology startup CrisprBits has developed PathCrisp, a platform for CRISPR-based molecular diagnostics for early detection of antibiotic resistance in hospital-acquired infections. <......
View Details
Source :
antibiotic resistance
rapid AMR detection
carbapenem resistance
Bengaluru startup
PathCrisp
CrisprBits Private Limited
CRISPR technology
Related News
- Joint team of police, drugs department and anti-narcotics task force raided warehouse, recovered huge quantity of Tramadol Pills (22-03-2025)
- Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)
- One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)
- List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)
- DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)
- Skin specialists flag widespread quackery in Kerala (21-03-2025)
- SHRC orders criminal proceedings against fake doctor (21-03-2025)
- Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)
- CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)
- FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)